The BIKEN Group is a Specialty Bio-Pharmaceutical Organization
specializing in Vaccines.
In 2017, the Research Foundation of Osaka University, BIKEN Foundation, and BIKEN Corporation started a new chapter known as the “BIKEN Group.”
We will combine our strengths and work for better public health both in Japan and the entire world.
Press Release & Update
-
2023/03/27Press Release
Approval of “GOBIK Aqueous Suspension Syringes”, Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine
-
2022/04/11Press Release
Marketing Authorization Application of Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine (BK1310/MT-2355)
-
2019/11/11Press Release
Regarding the Incident of Vaccine Culture Fluid Leakage at Seto Office
-
2017/05/09Press Release
Establishment of Vaccine Manufacturing Joint Venture: BIKEN Co.,Ltd.
-
2016/11/08Press Release
Basic Agreement on the Establishment of a Joint Venture
-
2016/09/06Press Release
BIKEN begins development of Zika virus vaccine, upon concluding agreement on virus distribution with Chiba Prefectural Institute of Health